Compared side by side

BPC-157 vs Thymosin Beta-4: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

BPC-157 is a peptide derived from a protective protein in human gastric juice; in animal studies it speeds the repair of tendons, ligaments, muscle and gut lining, partly by growing new blood vessels. Thymosin beta-4 is the full-length protein TB-500 is cut from: it regulates actin, the scaffolding cells use to move, and in animal studies it speeds tissue repair and supports new blood vessel growth. BPC-157 is taken once or twice daily and full thymosin beta-4 weekly, and neither has been tested by injection for injuries in a controlled human trial.

Side by side

ComparedBPC-157Thymosin Beta-4
CategoryHealing & recoveryHealing & recovery
Also known asBody Protection Compound 157, BPC157Tβ4, Full TB4
What it isA peptide derived from a protective protein in your stomach.The full-length version of the protein TB-500 is cut from.
How it worksSynthetic pentadecapeptide derived from a protein in human gastric juice. In animal studies it promotes angiogenesis, speeds tendon, ligament and muscle healing, modulates dopamine and serotonin systems, and protects the gut lining.Full-length Thymosin Beta-4 (as opposed to the TB-500 fragment). In cell and animal studies it promotes tissue repair, angiogenesis and cell survival. Regulates actin dynamics and plays a role in embryonic development and wound healing.
Commonly reportedFaster recovery from tendon and ligament injuries, and a calmer gut. It's one of the most widely used peptides in the community; the human studies so far are three small uncontrolled pilots.Less nagging joint and soft-tissue pain and stiffness over a few weeks, and sometimes tiredness for a day after injecting. Its human trials are small eye-drop and skin-gel studies; injected use for injuries hasn't been tested in people.
Studied rangeResearch range: 200–500 mcg. Studied in research — not a recommendation.Research range: 2–2.5 mg. Studied in research — not a recommendation.
How oftenOnce or twice dailyWeekly
Half-life~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes)~0.5–2 hours (given IV to healthy volunteers)
RouteSubQ injection, IM injection, Oral (less studied)SubQ injection, IM injection
Typical runTypically 4–12 weeks. Many run until injury resolves then stop. Some run indefinitely at lower doses. Opinions vary widely.Shorter cycles than TB-500 typical — 4–6 weeks. Less community data than TB-500 fragment.
EvidenceEmerging: primarily preclinical / limited human dataEmerging: primarily preclinical / limited human data
Common side effectsNausea (rare), injection site irritation, vivid dreams, dizzinessInjection site reaction, fatigue, headache

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking BPC-157 or Thymosin Beta-4? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

BPC-157

  • Day 1–7 Week one: early hints, for some
  • Day 7–14 Pain often starts to ease
  • Day 14–21 Pain often eases by week three
  • Day 21–28 Many report a calmer gut
  • Day 28–42 The slower part of repair
  • Day 42–56 Six weeks in: taking stock
  • Day 84+ Past week 12, the data runs thin

Every card for BPC-157, with its sources

Thymosin Beta-4

  • Day 1–14 The full protein, not the fragment
  • Day 14–28 Weeks 2 to 4: how the injury responds

Every card for Thymosin Beta-4, with its sources

Together or one or the other

BPC-157 and Thymosin Beta-4 are a common stack: Thymosin Beta-4 lists BPC-157 among its common stacks.

Community · Thymosin Beta-4

Full Tβ4 + BPC-157: local plus body-wide

BPC-157 works on local repair at the injury site, while full thymosin beta-4 helps repair cells move in from further afield. Commonly reported: faster recovery from stubborn soft-tissue injuries.

Questions people ask

How long do BPC-157 and Thymosin Beta-4 last?

The half-life of BPC-157 is ~4–6 hours (community estimate for SubQ; not measured in people: in rats and dogs it cleared in under 30 minutes). The half-life of Thymosin Beta-4 is ~0.5–2 hours (given IV to healthy volunteers).

How often are BPC-157 and Thymosin Beta-4 taken?

BPC-157: once or twice daily. Routes: SubQ injection, IM injection, oral (less studied). Thymosin Beta-4: weekly. Routes: SubQ injection, IM injection.

How are BPC-157 and Thymosin Beta-4 dosed in research?

The research range for BPC-157 is 200–500 mcg. The research range for Thymosin Beta-4 is 2–2.5 mg. Studied in research — not a recommendation.

What are the common side effects of BPC-157 and Thymosin Beta-4?

For BPC-157, the library lists: nausea (rare), injection site irritation, vivid dreams, dizziness. For Thymosin Beta-4: injection site reaction, fatigue, headache.

Are BPC-157 and Thymosin Beta-4 taken together?

BPC-157 and Thymosin Beta-4 are a common stack: Thymosin Beta-4 lists BPC-157 among its common stacks. BPC-157 works on local repair at the injury site, while full thymosin beta-4 helps repair cells move in from further afield. Commonly reported: faster recovery from stubborn soft-tissue injuries.

Each one in full

Track it in the app

PepVault for iPhone

Taking BPC-157 or Thymosin Beta-4? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo